Growth Metrics

LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

LifeMD filings provide 4 years of Preferred Stock Liabilities readings, the most recent being $5.0 million for Q2 2023.

  • On a quarterly basis, Preferred Stock Liabilities rose 16.06% to $5.0 million in Q2 2023 year-over-year; TTM through Jun 2023 was $5.0 million, a 16.06% increase, with the full-year FY2022 number at $4.6 million, up 11.07% from a year prior.
  • Preferred Stock Liabilities hit $5.0 million in Q2 2023 for LifeMD, up from $4.7 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $5.0 million in Q2 2023 to a low of $3.7 million in Q4 2020.
  • Median Preferred Stock Liabilities over the past 4 years was $4.2 million (2022), compared with a mean of $4.2 million.
  • The widest YoY moves for Preferred Stock Liabilities: up 16.06% in 2023, down 10.77% in 2023.
  • LifeMD's Preferred Stock Liabilities stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then grew by 11.07% to $4.6 million in 2022, then increased by 10.23% to $5.0 million in 2023.
  • The last three reported values for Preferred Stock Liabilities were $5.0 million (Q2 2023), $4.7 million (Q1 2023), and $4.6 million (Q4 2022) per Business Quant data.